To include your compound in the COVID-19 Resource Center, submit it here.

Mirati up after $80M follow-on

Mirati Therapeutics Inc. (NASDAQ:MRTX) gained $4.95 (35%) to $19 on Thursday after raising $80 million through the sale of

Read the full 190 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE